High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug responseHui Gao, Zongyao Wang, Youzhen Wang et al.|Nature Medicine|2015Cited by 1.4k
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistanceMeghna Das Thakur, Darrin D. Stuart, Allison Landman et al.|Nature|2013Cited by 735